Advertisement
Screener

AGILENT TECHNOLOGIES, INC. (A) Overview

AGILENT TECHNOLOGIES, INC. (A) Overview

  • 1 May 2026: Period ending 31 Jul 2026; Estimate (m); Actual 1.28; Beat / miss (m).
  • 1 Feb 2026: Period ending 30 Apr 2026; Estimate (m); Actual 1.20; Beat / miss (m).
  • 1 Nov 2025: Period ending 31 Jan 2026; Estimate (m); Actual 1.07; Beat / miss (m).
  • 1 May 2025: Period ending 31 Jul 2025; Estimate (m); Actual 1.18; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$104.73$117.37$131.54$147.42$165.22$185.162025-11-062026-11-06$94.33$108.56$124.94$143.80$165.50$190.472021-11-082026-11-06$41.05$56.27$77.12$105.71$144.89$198.602016-11-072026-11-06$8.45$16.04$30.46$57.83$109.79$208.432006-11-062026-11-06$7.37$14.56$28.74$56.74$112.03$221.191999-11-182026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$174.75
Previous close
$175.03
Change
-$0.28
Change (%)
-0.16%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

A
+29.46%
S&P 500
(m)

1 year

A
+42.64%
S&P 500
(m)

3 years

A
+60.22%
S&P 500
(m)

5 years

A
+13.40%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Jul 2026 ○ Estimate (m) ● Actual 1.28

0.670.871.061.261.4630 Apr 2025: estimate (m); actual 0.7530 Apr 2025(m)31 Jul 2025: estimate (m); actual 1.1831 Jul 2025(m)31 Jan 2026: estimate (m); actual 1.0731 Jan 2026(m)30 Apr 2026: estimate (m); actual 1.2030 Apr 2026(m)31 Jul 2026: estimate (m); actual 1.2831 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 May 202631 Jul 2026(m)1.28(m)(m)
1 Feb 202630 Apr 2026(m)1.20(m)(m)
1 Nov 202531 Jan 2026(m)1.07(m)(m)
1 May 202531 Jul 2025(m)1.18(m)(m)
1 Feb 202530 Apr 2025(m)0.75(m)(m)

31 Oct 2025 ○ Estimate (m) ● Actual 4.57

3.864.084.304.534.7531 Oct 2021: estimate (m); actual 3.9431 Oct 2021(m)31 Oct 2022: estimate (m); actual 4.1831 Oct 2022(m)31 Oct 2023: estimate (m); actual 4.1931 Oct 2023(m)31 Oct 2024: estimate (m); actual 4.4331 Oct 2024(m)31 Oct 2025: estimate (m); actual 4.5731 Oct 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Nov 202431 Oct 2025(m)4.57(m)(m)
1 Nov 202331 Oct 2024(m)4.43(m)(m)
1 Nov 202231 Oct 2023(m)4.19(m)(m)
1 Nov 202131 Oct 2022(m)4.18(m)(m)
1 Nov 202031 Oct 2021(m)3.94(m)(m)

Revenue vs. Earnings

USD

31 Jul 2026 ■ Revenue 1.88B ■ Earnings 0.36B — Profit margin 19.28%

-0.23B16.0%0.55B17.4%1.33B18.9%2.10B20.3%31 Jul 2025: revenue 1.74B; earnings 0.34B; profit margin 19.33%31 Jul 202531 Jan 2026: revenue 1.80B; earnings 0.30B; profit margin 16.96%31 Jan 202630 Apr 2026: revenue 1.83B; earnings 0.34B; profit margin 18.47%30 Apr 202631 Jul 2026: revenue 1.88B; earnings 0.36B; profit margin 19.28%31 Jul 2026

31 Oct 2025 ■ Revenue 6.95B ■ Earnings 1.30B — Profit margin 18.75%

-0.83B17.1%2.04B18.4%4.91B19.6%7.78B20.8%31 Oct 2022: revenue 6.85B; earnings 1.25B; profit margin 18.31%31 Oct 202231 Oct 2023: revenue 6.83B; earnings 1.24B; profit margin 18.15%31 Oct 202331 Oct 2024: revenue 6.51B; earnings 1.29B; profit margin 19.80%31 Oct 202431 Oct 2025: revenue 6.95B; earnings 1.30B; profit margin 18.75%31 Oct 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$174.75(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$174.75High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning A

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
18.10K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.49M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
4.61%*
Total return · month
13.78%*
Total return · quarter
32.09%*
Total return · half year
59.51%*
Total return · year to date
29.46%*
Total return · 1 year
42.64%*
Total return · 3 years
60.22%*
Total return · 5 years
13.40%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

AGILENT TECHNOLOGIES, INC. Overview

View more →

(m)

(m)

SEC CIK
1090872
Industry (SIC)
3826 Laboratory Analytical Instruments
Country of operation
United States
Business address
5301 STEVENS CREEK BLVD, SANTA CLARA, California, 95051, United States
Fiscal year end
1031
Phone
(408) 345-8886

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
ILLUMINA, INC. (ILMN)United States$41.357B32.37
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53